Nurix Therapeutics, Inc. - COM (NRIX)

Historical Portfolio Holders from Q3 2020 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / COM
Shares, excl. options Q3 2024
67.6M
Holdings value Q3 2024
$1.52B
Value change Q3 2024
+$52.7M
Grand Portfolio weight change Q3 2024
+0%
Number of holders
169
Number of buys Q3 2024
91
Number of sells Q3 2024
-86
Average buys Q3 2024 %
+0.001%
Average sells Q3 2024 %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 67.6M $1.52B +$52.7M $22.47 169
2024 Q2 65M $1.36B +$344M $20.87 172
2024 Q1 48.9M $718M +$49.1M $14.70 136
2023 Q4 46.1M $476M +$17.7M $10.32 126
2023 Q3 44.8M $352M +$8.47M $7.86 128
2023 Q2 43.6M $436M +$11.8M $9.99 123
2023 Q1 42.5M $377M -$3.11M $8.88 120
2022 Q4 42.7M $469M +$2.14M $10.98 118
2022 Q3 43.1M $561M -$38.3M $13.03 113
2022 Q2 44.9M $568M +$55.4M $12.67 101
2022 Q1 40.4M $566M -$19.3M $14.01 111
2021 Q4 40.4M $1.17B +$25.9M $28.95 121
2021 Q3 39.4M $1.18B -$12M $29.96 110
2021 Q2 39.5M $1.05B -$66.7M $26.53 103
2021 Q1 41.3M $1.29B +$254M $31.09 99
2020 Q4 33.1M $1.09B +$26.9M $32.88 67
2020 Q3 31.9M $1.11B +$1.11B $34.91 64